Clinical Trial Update: Research Study in Patients With Severe Ulcerative Colitis [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/Phase 3 clinical trial evaluating a treatment for severe ulcerative colitis sponsored by Facet Biotech.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Snippet

Sponsor: Facet Biotech | Conditions: Ulcerative Colitis | Phase 2, Phase 3 | Status: COMPLETED